Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2023

Open Access 01-12-2023 | Canagliflozin | Research

Hierarchical network meta-analysis models for synthesis of evidence from randomised and non-randomised studies

Authors: Humaira Hussein, Keith R. Abrams, Laura J. Gray, Sumayya Anwer, Sofia Dias, Sylwia Bujkiewicz

Published in: BMC Medical Research Methodology | Issue 1/2023

Login to get access

Abstract

Background

With the increased interest in the inclusion of non-randomised data in network meta-analyses (NMAs) of randomised controlled trials (RCTs), analysts need to consider the implications of the differences in study designs as such data can be prone to increased bias due to the lack of randomisation and unmeasured confounding. This study aims to explore and extend a number of NMA models that account for the differences in the study designs, assessing their impact on the effect estimates and uncertainty.

Methods

Bayesian random-effects meta-analytic models, including naïve pooling and hierarchical models differentiating between the study designs, were extended to allow for the treatment class effect and accounting for bias, with further extensions allowing for bias terms to vary depending on the treatment class. Models were applied to an illustrative example in type 2 diabetes; using data from a systematic review of RCTs and non-randomised studies of two classes of glucose-lowering medications: sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists.

Results

Across all methods, the estimated mean differences in glycated haemoglobin after 24 and 52 weeks remained similar with the inclusion of observational data. The uncertainty around these estimates reduced when conducting naïve pooling, compared to NMA of RCT data alone, and remained similar when applying hierarchical model allowing for class effect. However, the uncertainty around these effect estimates increased when fitting hierarchical models allowing for the differences in study design. The impact on uncertainty varied between treatments when applying the bias adjustment models. Hierarchical models and bias adjustment models all provided a better fit in comparison to the naïve-pooling method.

Conclusions

Hierarchical and bias adjustment NMA models accounting for study design may be more appropriate when conducting a NMA of RCTs and observational studies. The degree of uncertainty around the effectiveness estimates varied depending on the method but use of hierarchical models accounting for the study design resulted in increased uncertainty. Inclusion of non-randomised data may, however, result in inferences that are more generalisable and the models accounting for the differences in the study design allow for more detailed and appropriate modelling of complex data, preventing overly optimistic conclusions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). The Cochrane Collaboration; 2020. Available from: www.training.cochrane.org/handbook. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). The Cochrane Collaboration; 2020. Available from: www.​training.​cochrane.​org/​handbook.
2.
go back to reference Evans D. Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions. J Clin Nurs. 2003;12(1):77–84.CrossRefPubMed Evans D. Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions. J Clin Nurs. 2003;12(1):77–84.CrossRefPubMed
3.
go back to reference Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral
4.
go back to reference Hill N, Frappier-Davignon L, Morrison B. The periodic health examination. Can Med Assoc J. 1979;121:1193–254. Hill N, Frappier-Davignon L, Morrison B. The periodic health examination. Can Med Assoc J. 1979;121:1193–254.
5.
go back to reference Welton NJ, Sutton AJ, Cooper N, Abrams KR, Ades AE. Evidence synthesis for decision making in healthcare. Chichester: Wiley; 2012.CrossRef Welton NJ, Sutton AJ, Cooper N, Abrams KR, Ades AE. Evidence synthesis for decision making in healthcare. Chichester: Wiley; 2012.CrossRef
6.
go back to reference Sarri G, Patorno E, Yuan H, Guo JJ, Bennett D, Wen X, et al. Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making. BMJ Evid Based Med. 2022;27(2):109–19.CrossRefPubMed Sarri G, Patorno E, Yuan H, Guo JJ, Bennett D, Wen X, et al. Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making. BMJ Evid Based Med. 2022;27(2):109–19.CrossRefPubMed
8.
go back to reference Efthimiou O, Mavridis D, Debray TP, Samara M, Belger M, Siontis GC, et al. Combining randomized and non-randomized evidence in network meta-analysis. Stat Med. 2017;36(8):1210–26.CrossRefPubMed Efthimiou O, Mavridis D, Debray TP, Samara M, Belger M, Siontis GC, et al. Combining randomized and non-randomized evidence in network meta-analysis. Stat Med. 2017;36(8):1210–26.CrossRefPubMed
9.
go back to reference Schmitz S, Adams R, Walsh C. Incorporating data from various trial designs into a mixed treatment comparison model. Stat Med. 2013;32(17):2935–49.CrossRefPubMed Schmitz S, Adams R, Walsh C. Incorporating data from various trial designs into a mixed treatment comparison model. Stat Med. 2013;32(17):2935–49.CrossRefPubMed
10.
go back to reference Verde PE. A bias-corrected meta-analysis model for combining, studies of different types and quality. Biom J. 2021;63(2):406–22.CrossRefPubMed Verde PE. A bias-corrected meta-analysis model for combining, studies of different types and quality. Biom J. 2021;63(2):406–22.CrossRefPubMed
11.
go back to reference Verde PE, Ohmann C. Combining randomized and non-randomized evidence in clinical research: a review of methods and applications. Res Synth Methods. 2015;6(1):45–62.CrossRefPubMed Verde PE, Ohmann C. Combining randomized and non-randomized evidence in clinical research: a review of methods and applications. Res Synth Methods. 2015;6(1):45–62.CrossRefPubMed
12.
go back to reference Dias S, Sutton AJ, Welton NJ, Ades A. NICE DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment. 2011. Dias S, Sutton AJ, Welton NJ, Ades A. NICE DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment. 2011.
13.
go back to reference Faria R, Alava MH, Manca A, Wailoo AJ. NICE DSU technical support document 17: the use of observational data to inform estimates of treatment effectiveness for Technology Appraisal: Methods for comparative individual patient data. 2015. Available from: http://www.nicedsu.org.uk. Faria R, Alava MH, Manca A, Wailoo AJ. NICE DSU technical support document 17: the use of observational data to inform estimates of treatment effectiveness for Technology Appraisal: Methods for comparative individual patient data. 2015. Available from: http://​www.​nicedsu.​org.​uk.
14.
go back to reference Begg CB, Pilote L. A model for incorporating historical controls into a meta-analysis. Biometrics. 1991;47(3):899–906.CrossRefPubMed Begg CB, Pilote L. A model for incorporating historical controls into a meta-analysis. Biometrics. 1991;47(3):899–906.CrossRefPubMed
15.
go back to reference Dias S, Welton N, Marinho V, Salanti G, Higgins JP, Ades A. Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis. J R Stat Soc A Stat Soc. 2010;173(3):613–29.CrossRef Dias S, Welton N, Marinho V, Salanti G, Higgins JP, Ades A. Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis. J R Stat Soc A Stat Soc. 2010;173(3):613–29.CrossRef
16.
go back to reference Hussein H, Zaccardi F, Khunti K, Davies MJ, Patsko E, Dhalwani NN, et al. Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis. Diabetes Obes Metab. 2020;22(7):1035–46.CrossRefPubMed Hussein H, Zaccardi F, Khunti K, Davies MJ, Patsko E, Dhalwani NN, et al. Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis. Diabetes Obes Metab. 2020;22(7):1035–46.CrossRefPubMed
17.
go back to reference Owen RK, Tincello DG, Abrams KR. Network meta-analysis: development of a three-level hierarchical modeling approach incorporating dose-related constraints. Value Health. 2015;18(1):116–26.CrossRefPubMed Owen RK, Tincello DG, Abrams KR. Network meta-analysis: development of a three-level hierarchical modeling approach incorporating dose-related constraints. Value Health. 2015;18(1):116–26.CrossRefPubMed
18.
go back to reference Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS-a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10(4):325–37.CrossRef Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS-a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10(4):325–37.CrossRef
19.
go back to reference Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc B Stat Methodol. 2002;64(4):583–639.CrossRef Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc B Stat Methodol. 2002;64(4):583–639.CrossRef
20.
go back to reference Ioannidis JP, Haidich A-B, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA. 2001;286(7):821–30.CrossRefPubMed Ioannidis JP, Haidich A-B, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA. 2001;286(7):821–30.CrossRefPubMed
21.
go back to reference Jenkins DA, Hussein H, Martina R, Dequen-O’Byrne P, Abrams KR, Bujkiewicz S. Methods for the inclusion of real-world evidence in network meta-analysis. BMC Med Res Methodol. 2021;21(1):1–9.CrossRef Jenkins DA, Hussein H, Martina R, Dequen-O’Byrne P, Abrams KR, Bujkiewicz S. Methods for the inclusion of real-world evidence in network meta-analysis. BMC Med Res Methodol. 2021;21(1):1–9.CrossRef
22.
go back to reference Hussein H, Nevill CR, Meffen A, Abrams KR, Bujkiewicz S, Sutton AJ, et al. Double-counting of populations in evidence synthesis in public health: a call for awareness and future methodological development. BMC Public Health. 2022;22(1):1–10. Hussein H, Nevill CR, Meffen A, Abrams KR, Bujkiewicz S, Sutton AJ, et al. Double-counting of populations in evidence synthesis in public health: a call for awareness and future methodological development. BMC Public Health. 2022;22(1):1–10.
23.
go back to reference Hamza T, Chalkou K, Pellegrini F, Kuhle J, Benkert P, Lorscheider J, et al. Synthesizing cross‐design evidence and cross‐format data using network meta‐regression. Res Synth Methods. Res Syn Meth. 2023;14:283–300. Hamza T, Chalkou K, Pellegrini F, Kuhle J, Benkert P, Lorscheider J, et al. Synthesizing cross‐design evidence and cross‐format data using network meta‐regression. Res Synth Methods. Res Syn Meth. 2023;14:283–300.
Metadata
Title
Hierarchical network meta-analysis models for synthesis of evidence from randomised and non-randomised studies
Authors
Humaira Hussein
Keith R. Abrams
Laura J. Gray
Sumayya Anwer
Sofia Dias
Sylwia Bujkiewicz
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Canagliflozin
Published in
BMC Medical Research Methodology / Issue 1/2023
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-023-01925-5

Other articles of this Issue 1/2023

BMC Medical Research Methodology 1/2023 Go to the issue